JP Morgan Chase’s Compugen CGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-50,000
Closed -$414K 6503
2021
Q2
$414K Hold
50,000
﹤0.01% 4817
2021
Q1
$430K Buy
+50,000
New +$554K ﹤0.01% 4768

Other funds holding CGEN

JP Morgan Chase's CGEN Position: Q1 2026 in Review

JP Morgan Chase reduced its Compugen (CGEN) stake by 29% in Q1 2026, selling an estimated $1.66K and leaving 2,070 shares worth $4.12K. The position accounts for ﹤0.01% of the portfolio, ranked #6914.

JP Morgan Chase first reported a position in CGEN in Q2 2017 and has held it in 25 quarters since. The position peaked at $2.22M in Q1 2021. 78 funds tracked by Wall St. Rank hold CGEN as of Q1 2026.

  • JP Morgan Chase held 2,070 shares of Compugen worth $4.12K as of Q1 2026.
  • JP Morgan Chase sold 856 Compugen shares in Q1 2026, an estimated $1.66K.
  • Compugen made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #6914 holding.
  • JP Morgan Chase first reported a position in Compugen in Q2 2017 and has held it in 25 quarters since.
  • JP Morgan Chase's Compugen position peaked at $2.22M in Q1 2021.
  • 78 funds tracked by Wall St. Rank held Compugen as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.